Physician profile
Hannah Morehouse
NPI 1609220904
$10,659.11
in general payments reported to CMS, 2019-2025
12 companies · $258 in 2025
The $258 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $948 · 2020: $1,874 · 2021: $1,200 · 2022: $33.57 · 2023: $774 · 2024: $5,572 · 2025: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,281 · Food and Beverage: $1,322.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,281.32 |
| Food and Beverage | $1,322.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cgg Medical INC | $4,062.15 | 2024-2025 | |
| Medinc of Texas | $4,022.00 | 2019-2021 | |
| Arthrex, INC. | $1,104.70 | 2024 | |
| Stryker Corporation | $921.64 | 2022-2025 | Mako, Pangea |
| Smith+Nephew, INC. | $148.89 | 2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Djo, LLC | $112.27 | 2024-2025 | Cmf |
| Biocomposites INC | $102.18 | 2024 | |
| Bioventus LLC | $74.18 | 2023-2024 | Durolane, L360 Thigh System |
| Orthofix Medical, INC. | $50.36 | 2024-2025 | Physio-Stim, Accelstim |
| Ossur Americas, INC. | $21.31 | 2024 | Miami J |
| Paratek Pharmaceuticals, INC. | $19.91 | 2024 | Nuzyra |
| Stimlabs LLC | $19.52 | 2025 | Corplex P |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Morehouse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.